Literature DB >> 12853400

Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood.

Najib Aziz1, John L Fahey, Roger Detels, Anthony W Butch.   

Abstract

C-reactive protein (CRP) is an acute-phase reactant whose levels increase in response to a variety of inflammatory stimuli. Elevated levels in serum are observed after trauma, tissue necrosis, infection, surgery, and myocardial infarction and are associated with an increased risk of cardiovascular disease. CRP levels are also elevated in noninflammatory states, such as obesity, sleep disturbances, depression, chronic fatigue, aging, and physical inactivity. In this study, the performance of a highly sensitive CRP enzyme immunoassay was evaluated, along with common laboratory variables (specimen type, processing time, and storage conditions) that may influence measured blood concentrations of CRP. The measurement range of the assay was from 0.4 to 50 microg/liter. Total imprecision (coefficient of variation) ranged from 8.1 to 11.4%. CRP levels obtained with the enzyme immunoassay were highly correlated with those obtained with an automated immunonephelometric assay. Comparable results were obtained for plasma (heparin and EDTA treated) and serum samples, and levels were unaffected by delays in sample processing and storage temperature. CRP levels were also unaffected by up to seven freeze-thaw cycles. The median CRP concentration in healthy adults was determined to be 0.94 mg/liter, with a 95% working reference interval of 0 to 6.9 mg/liter. In view of these data, we recommend that serial serum or plasma samples for CRP should be stored at 4 degrees C for short periods of time or at -70 degrees C for longer periods and tested within the same run to minimize interassay variability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853400      PMCID: PMC164250          DOI: 10.1128/cdli.10.4.652-657.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  48 in total

Review 1.  C-reactive protein, inflammation, and coronary risk.

Authors:  D A Morrow; P M Ridker
Journal:  Med Clin North Am       Date:  2000-01       Impact factor: 5.456

2.  Rapid automated high sensitivity enzyme immunoassay of C-reactive protein.

Authors:  J Wilkins; J R Gallimore; E G Moore; M B Pepys
Journal:  Clin Chem       Date:  1998-06       Impact factor: 8.327

3.  Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range.

Authors:  S Eda; J Kaufmann; W Roos; S Pohl
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

4.  Serum C-reactive protein in pediatric kidney and liver transplant patients.

Authors:  Maria Their; Kai Rönnholm; Heikki Sairanen; Christer Holmberg; Hannu Jalanko
Journal:  Pediatr Transplant       Date:  2002-04

Review 5.  Immunonephelometric and immunoturbidimetric assays for proteins.

Authors:  J T Whicher; C P Price; K Spencer
Journal:  Crit Rev Clin Lab Sci       Date:  1983       Impact factor: 6.250

6.  Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease.

Authors:  J K Smith; R Dykes; J E Douglas; G Krishnaswamy; S Berk
Journal:  JAMA       Date:  1999-05-12       Impact factor: 56.272

Review 7.  Human C-reactive protein: expression, structure, and function.

Authors:  J E Volanakis
Journal:  Mol Immunol       Date:  2001-08       Impact factor: 4.407

8.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

Authors:  E M Macy; T E Hayes; R P Tracy
Journal:  Clin Chem       Date:  1997-01       Impact factor: 8.327

9.  High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy.

Authors:  H Yu; N Rifai
Journal:  Clin Biochem       Date:  2000-11       Impact factor: 3.281

10.  THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : I. DISTRIBUTION OF THE REACTIVE PROTEIN IN PATIENTS' SERA AND THE EFFECT OF CALCIUM ON THE FLOCCULATION REACTION WITH C POLYSACCHARIDE OF PNEUMOCOCCUS.

Authors:  T J Abernethy; O T Avery
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

View more
  37 in total

1.  Systemic inflammation and decline in lung function in a general population: a prospective study.

Authors:  Andrew W Fogarty; Stuart Jones; John R Britton; Sarah A Lewis; Tricia M McKeever
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

2.  Number of teeth, C-reactive protein, fibrinogen and cardiovascular mortality: a 15-year follow-up study in a Finnish cohort.

Authors:  Sok-Ja Janket; Alison E Baird; Judith A Jones; Elizabeth A Jackson; Markku Surakka; Wen Tao; Jukka H Meurman; Thomas E Van Dyke
Journal:  J Clin Periodontol       Date:  2013-12-10       Impact factor: 8.728

3.  A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.

Authors:  Tao Wang; Thomas E Rohan; Marc J Gunter; Xiaonan Xue; Jean Wactawski-Wende; Swapnil N Rajpathak; Mary Cushman; Howard D Strickler; Robert C Kaplan; Sylvia Wassertheil-Smoller; Philipp E Scherer; Gloria Y F Ho
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-17       Impact factor: 4.254

4.  Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis.

Authors:  Sarah R Horn; Madison M Long; Benjamin W Nelson; Nicholas B Allen; Philip A Fisher; Michelle L Byrne
Journal:  Brain Behav Immun       Date:  2018-06-19       Impact factor: 7.217

5.  Discriminative value of inflammatory biomarkers for suspected sepsis.

Authors:  Ephraim L Tsalik; L Brett Jaggers; Seth W Glickman; Raymond J Langley; Jennifer C van Velkinburgh; Lawrence P Park; Vance G Fowler; Charles B Cairns; Stephen F Kingsmore; Christopher W Woods
Journal:  J Emerg Med       Date:  2011-11-06       Impact factor: 1.484

6.  Effects of Transport Temperature on the Stability of Inflammatory, Hemostasis, Endothelial Function, and Oxidative Stress Plasma Biomarker Concentrations.

Authors:  Octavia M Peck Palmer; Melinda Carter; Chung-Chou H Chang; Nicole Lucko; Vanessa M Jackson; Qian Sun; Xinyan Xie; Melanie Scott; John A Kellum; Arvind Venkat; Sachin Yende
Journal:  Shock       Date:  2017-06       Impact factor: 3.454

7.  A novel haplotype within C-reactive protein gene influences CRP levels and coronary heart disease risk in Northwest Indians.

Authors:  Puneetpal Singh; Monica Singh; Harinder Singh Nagpal; Taranpal Kaur; Shallu Khullar; Gurpreet Kaur; Harjot Dhillon; Mario Di Napoli; Sarabjit Mastana
Journal:  Mol Biol Rep       Date:  2014-06-26       Impact factor: 2.316

8.  The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis.

Authors:  M I Danila; A O Westfall; K Raman; L Chen; R J Reynolds; L B Hughes; D K Arnett; G McGwin; A J Szalai; D M van der Heijde; D Conn; L F Callahan; L W Moreland; S L Bridges
Journal:  Genes Immun       Date:  2015-07-30       Impact factor: 2.676

9.  Synthesis of water-soluble CdSe quantum dots with various fluorescent properties and their application in immunoassay for determination of C-reactive protein.

Authors:  V K Gasparyan
Journal:  J Fluoresc       Date:  2014-07-18       Impact factor: 2.217

10.  Serum C-Reactive Protein (CRP), Target for Therapy or Trouble?

Authors:  Virginia B Kraus; Joanne M Jordan
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.